{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:15:04Z","timestamp":1770840904886,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jri.2019.07.006","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T11:23:07Z","timestamp":1565349787000},"page":"28-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["The effectiveness of IVIG therapy in pregnancy and live birth rate of women with recurrent implantation failure (RIF): A systematic review and meta-analysis"],"prefix":"10.1016","volume":"134-135","author":[{"given":"Samaneh","family":"Abdolmohammadi-Vahid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariba","family":"Pashazadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Pourmoghaddam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leili","family":"Aghebati-Maleki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedigheh","family":"Abdollahi-Fard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jri.2019.07.006_bib0005","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/humupd\/dml004","article-title":"Endometrial receptivity markers, the journey to successful embryo implantation","volume":"12","author":"Achache","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jri.2019.07.006_bib0010","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/19396368.2017.1390007","article-title":"Regulatory t cells improve pregnancy rate in rif patients after additional ivig treatment","volume":"63","author":"Ahmadi","year":"2017","journal-title":"Syst. Biol. Reprod. Med."},{"key":"10.1016\/j.jri.2019.07.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12784","article-title":"The role of immunological testing and intervention in reproductive medicine: a fertile collaboration?","volume":"79","author":"Ali","year":"2018","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2019.07.006_bib0020","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0140-6736(95)92539-2","article-title":"Preconceptional natural-killer-cell activity as a predictor of miscarriage","volume":"345","author":"Aoki","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jri.2019.07.006_bib0025","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2141.1988.tb02407.x","article-title":"Beneficial effect of intravenous gammaglobulin in a patient with complement\u2010mediated autoimmune thrombocytopenia due to igm\u2010anti\u2010platelet antibodies","volume":"69","author":"Brand","year":"1988","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jri.2019.07.006_bib0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0140-6736(88)92859-0","article-title":"Lupus anticoagulant and recurrent fetal loss: Successful treatment with gammaglobulin","volume":"332","author":"Carreras","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jri.2019.07.006_bib0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.imlet.2015.12.010","article-title":"Multiple immune deviations predictive for ivf failure as possible markers for ivig therapy","volume":"176","author":"Chernyshov","year":"2016","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jri.2019.07.006_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10815-005-9013-1","article-title":"Is intravenous immunoglobulins (ivig) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (ivf)","volume":"23","author":"Clark","year":"2006","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.jri.2019.07.006_bib0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/rmb2.12078","article-title":"Immune modulation of iv immunoglobulin in women with reproductive failure","volume":"17","author":"Han","year":"2018","journal-title":"Reprod. Med. Biol."},{"key":"10.1016\/j.jri.2019.07.006_bib0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1600-0897.2009.00790.x","article-title":"Cd3-cd56+cd16+ natural killer cells and improvement of pregnancy outcome in ivf\/icsi failure after additional ivig-treatment","volume":"63","author":"Heilmann","year":"2010","journal-title":"Am J Reprod Immunol. (New York, N.Y. : 1989)"},{"key":"10.1016\/j.jri.2019.07.006_bib0055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1600-0897.2009.00790.x","article-title":"Cd3\u2212 cd56+ cd16+ natural killer cells and improvement of pregnancy outcome in ivf\/icsi failure after additional ivig\u2010treatment","volume":"63","author":"Heilmann","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2019.07.006_bib0060","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1001\/jama.1995.03520480053039","article-title":"T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion","volume":"273","author":"Hill","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.jri.2019.07.006_bib0065","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/aji.12208","article-title":"Intravenous immunoglobulin g modulates peripheral blood t h17 and f oxp3+ regulatory t cells in pregnant women with recurrent pregnancy loss","volume":"71","author":"Kim","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2019.07.006_bib0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/aji.12234","article-title":"Immunological modes of pregnancy loss: inflammation, immune effectors, and stress","volume":"72","author":"Kwak\u2010Kim","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2019.07.006_bib0075","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/humrep\/deg156","article-title":"Increased t helper 1 cytokine responses by circulating t cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after ivf","volume":"18","author":"Kwak\u2010Kim","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jri.2019.07.006_bib0080","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1600-0897.1996.tb00495.x","article-title":"Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin g infusion in women with recurrent spontaneous abortions","volume":"35","author":"Kwak","year":"1996","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2019.07.006_bib0085","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/aji.12170","article-title":"Intravenous immunoglobulin treatment for repeated ivf\/icsi failure and unexplained infertility: A systematic review and a meta\u2010analysis","volume":"70","author":"Li","year":"2013","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2019.07.006_bib0090","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The prisma statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jri.2019.07.006_bib0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0897.2012.01135.x","article-title":"Intravenous immunoglobulin treatment increased live birth rate in a spanish cohort of women with recurrent reproductive failure and expanded cd56(+) cells","volume":"68","author":"Moraru","year":"2012","journal-title":"Am. J. Reprod. Immunol. (New York, N.Y. : 1989)"},{"key":"10.1016\/j.jri.2019.07.006_bib0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0897.2012.01135.x","article-title":"Intravenous immunoglobulin treatment increased live birth rate in a s panish cohort of women with recurrent reproductive failure and expanded cd 56+ cells","volume":"68","author":"Moraru","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2019.07.006_bib0105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1034\/j.1600-0897.2001.d01-31.x","article-title":"Massive intravenous immunoglobulin treatment in women with four or more recurrent spontaneous abortions of unexplained etiology: Down\u2010regulation of nk cell activity and subsets","volume":"46","author":"Morikawa","year":"2001","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2019.07.006_bib0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1515\/CCLM.2004.065","article-title":"Intravenous immunoglobulin (ivig): Modes of action in the clinical management of recurrent pregnancy loss (rpl) and selected autoimmune disorders","volume":"42","author":"Omwandho","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jri.2019.07.006_bib0115","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/aji.12217","article-title":"Experience in ivig therapy for selected women with recurrent reproductive failure and nk cell expansion","volume":"71","author":"Ramos-Medina","year":"2014","journal-title":"Am. J. Reprod. Immunol. (New York, N.Y. : 1989)"},{"key":"10.1016\/j.jri.2019.07.006_bib0120","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/aji.12217","article-title":"Experience in ivi g therapy for selected women with recurrent reproductive failure and nk cell expansion","volume":"71","author":"Ramos\u2010Medina","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2019.07.006_bib0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: how does igg modulate the immune system?","volume":"13","author":"Schwab","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jri.2019.07.006_bib0130","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s10815-012-9861-4","article-title":"Assessment and treatment of repeated implantation failure (rif)","volume":"29","author":"Simon","year":"2012","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.jri.2019.07.006_bib0135","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0015-0282(00)01622-8","article-title":"Treatment of repeated unexplained in vitro fertilization failure with intravenous immunoglobulin: a randomized, placebo-controlled Canadian trial","volume":"74","author":"Stephenson","year":"2000","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2019.07.006_bib0140","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/humrep\/deh378","article-title":"An increase in the absolute count of cd56dimcd16+ cd69+ nk cells in the peripheral blood is associated with a poorer ivf treatment and pregnancy outcome","volume":"19","author":"Thum","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jri.2019.07.006_bib0145","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/XEB.0000000000000065","article-title":"Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness","volume":"13","author":"Tufanaru","year":"2015","journal-title":"Int. J. Evid. Healthc."},{"key":"10.1016\/j.jri.2019.07.006_bib0150","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1600-0897.2007.00529.x","article-title":"Decline in number of elevated blood cd3+ cd56+ nkt cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy","volume":"58","author":"Van Den Heuvel","year":"2007","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2019.07.006_bib0155","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0897.2012.01169.x","article-title":"Intravenous immunoglobulin for repeated ivf failure and unexplained infertility","volume":"68","author":"Virro","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2019.07.006_bib0160","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0897.2011.01018.x","article-title":"Elevated preconception cd56+ 16+ and\/or th1: Th2 levels predict benefit from ivig therapy in subfertile women undergoing ivf","volume":"66","author":"Winger","year":"2011","journal-title":"Am. J. Reprod. Immunol."}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037819300415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037819300415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:25:07Z","timestamp":1759033507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165037819300415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":32,"alternative-id":["S0165037819300415"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2019.07.006","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effectiveness of IVIG therapy in pregnancy and live birth rate of women with recurrent implantation failure (RIF): A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2019.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}